32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

The need for safer therapeutics contra gastrointestinal infections with lowered harmful effect on positive gut microbiota is discussed in this work, mainly in respect to the increasing pathogen resistance to antibiotics. Since many phytocompounds possess strong specific antimicrobial activity, this work is focused on selectively acting plant-derived products in the context of their inhibitory activity towards gut pathogens versus their reduced impact on beneficial resident gut microbiota of humans. Resulting from the experimental part, a natural alkaloid 8-hydroxyquinoline (8HQ) was selected…mehr

Produktbeschreibung
The need for safer therapeutics contra gastrointestinal infections with lowered harmful effect on positive gut microbiota is discussed in this work, mainly in respect to the increasing pathogen resistance to antibiotics. Since many phytocompounds possess strong specific antimicrobial activity, this work is focused on selectively acting plant-derived products in the context of their inhibitory activity towards gut pathogens versus their reduced impact on beneficial resident gut microbiota of humans. Resulting from the experimental part, a natural alkaloid 8-hydroxyquinoline (8HQ) was selected as the phytocompound with the most pronounced selectivity out of the 26 plant-derived products tested. Its activity was scrutinized also by a method combining fluorescent in situ hybridization and flow cytometry. Furthermore, the selectivity of 8HQ was practically utilized for development of improved selective medium for bifidobacteria isolation from feces. Conclusively, further research of phytocompounds as safer antibacterial agents is suggested.
Autorenporträt
The author obtained Ph.D. at Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague. Currently, she works as postdoc researcher at the same university, at Faculty of Agrobiology, Food and Natural Resources. Her research is focused on plant-derived biologically active products, with special attention to antimicrobial activity.